BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34535287)

  • 1. Factor XI Deficiency.
    Lewandowska MD; Connors JM
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1157-1169. PubMed ID: 34535287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
    Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
    Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency.
    Alsammak MS; Ashrani AA; Winters JL; Pruthi RK
    J Clin Apher; 2017 Dec; 32(6):429-436. PubMed ID: 28295573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemostatic role of factor XI.
    Puy C; Rigg RA; McCarty OJ
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment.
    Barg AA; Livnat T; Kenet G
    Blood; 2024 Apr; 143(15):1455-1464. PubMed ID: 38194679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report.
    Burgos Pratx LD; Santoro DM; Mileo FG; Martinuzzo ME; Ardiles V; de Santibañes E; Salamone HJ
    Transfus Apher Sci; 2021 Oct; 60(5):103176. PubMed ID: 34127376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital factor XI deficiency: an update.
    Duga S; Salomon O
    Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical management of factor XI deficiency in pregnant women.
    Wheeler AP; Hemingway C; Gailani D
    Expert Rev Hematol; 2020 Jul; 13(7):719-729. PubMed ID: 32437625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
    Bertaggia Calderara D; Zermatten MG; Aliotta A; Batista Mesquita Sauvage AP; Carle V; Heinis C; Alberio L
    Thromb Haemost; 2021 Feb; 121(2):150-163. PubMed ID: 32920807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein.
    Ay C; Hisada Y; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Sep; 15(9):1829-1833. PubMed ID: 28677246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene targeting in hemostasis. factor XI.
    Gailani D
    Front Biosci; 2001 Feb; 6():D201-7. PubMed ID: 11171549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric severe factor XI deficiency: A multicenter study.
    Barg AA; Levy-Mendelovich S; Budnik I; Mandel-Shorer N; Dardik R; Avishai E; Brutman-Barazani T; Ifrah AD; Oren-Malek L; Yacobovich J; Gilad O; Nakav S; Fruchtman Y; Revel-Vilk S; Miskin H; Kenet G
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29545. PubMed ID: 34957695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PERIOPERATIVE MANAGEMENT OF AN ADOLESCENT GIRL WITH SEVERE FACTOR XI DEFICIENCY AND INHIBITORS].
    Mandel-Shorer N; Oren-Malek L; Keren-Politansky A; Berger-Achituv S; Revel-Vilk S
    Harefuah; 2023 Jan; 162(1):42-46. PubMed ID: 36714941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI promotes hemostasis in factor IX-deficient mice.
    Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D
    J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia.
    Peyvandi F; Lak M; Mannucci PM
    Haematologica; 2002 May; 87(5):512-4. PubMed ID: 12010665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor XI as a novel target for antithrombotic treatment.
    Löwenberg EC; Meijers JC; Monia BP; Levi M
    J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors.
    Salomon O; Gailani D
    J Thromb Haemost; 2022 Jan; 20(1):32-38. PubMed ID: 34735741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Management of Factor XI Deficiency in Pregnancy.
    Davies J; Kadir R
    Semin Thromb Hemost; 2016 Oct; 42(7):732-740. PubMed ID: 27699729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
    Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
    Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.
    Zucker M; Seligsohn U; Salomon O; Wolberg AS
    J Thromb Haemost; 2014 Jul; 12(7):1121-30. PubMed ID: 24815347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.